|
2007 Journal Article An assessment of the role of SREBP 1 C in the pathogenesis of HCV-related steatosisMcPhersonS, Jonsson, JR, BarrieHD, CloustonAD and PowellEE (2007). An assessment of the role of SREBP 1 C in the pathogenesis of HCV-related steatosis. Hepatology, 46 (4), 438A-438A. |
|
2007 Journal Article Progressive fibrosis in nonalcoholic steato hepatitis: Association with altered regeneration and a ductular reactionRichardson M. M., Jonsson, J. R., Powell, E. E., Brunt, EM, Neuschwander-Tetri, BA, Bhathal, PS, Dixon, JB, Weltman, MD, Tilg, H, Moschen, AR, Purdie, DM, Demetris, AJ and Clouston, A. D. (2007). Progressive fibrosis in nonalcoholic steato hepatitis: Association with altered regeneration and a ductular reaction. Gastroenterology, 133 (1), 80-90. doi: 10.1053/j.gastro.2007.05.012 |
|
2007 Journal Article Progressive fibrosis in non-alcoholic steatohepatitis - Association with altered regeneration and a ductular reactionRichardsonMM, Jonsson, JR, PowellEE, BruntEM, Neuschwander-TetriBA, BhathalPS, DixonJB, WeltmanMD, TilgH, MoschenAR, PurdieDM, DemetrisAJ and CloustonAD (2007). Progressive fibrosis in non-alcoholic steatohepatitis - Association with altered regeneration and a ductular reaction. Journal of Hepatology, 46, S49-S50. doi: 10.1016/S0168-8278(07)61711-5 |
|
2007 Journal Article An assessment of the role of endoplasmic reticulum (ER) stress in the pathogenesis of HCVMcPhersonS, PowellEE, BarrieHD, CloustonAD and Jonsson, JR (2007). An assessment of the role of endoplasmic reticulum (ER) stress in the pathogenesis of HCV. Hepatology, 46 (4), 444A-444A. |
|
2006 Journal Article Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1Walsh, MJ, Jonsson, JR, Richardson, MM, Lipka, GM, Purdie, DM, Clouston, D and Powell, EE (2006). Non-response to antiviral therapy is associated with obesity and increased hepatic expression of suppressor of cytokine signalling 3 (SOCS-3) in patients with chronic hepatitis C, viral genotype 1. Gut, 55 (4), 529-535. doi: 10.1136/gut.2005.069674 |
|
2006 Journal Article Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: A meta-analysis of individual patient dataLeandro, G, Mangia, A, Hui, J, Fabris, P, Rubbia-Brandt, L, Colloredo, G, Adinolfi, LE, Asselah, T, Jonsson, JR, Smedile, A, Terrault, N, Pazienza, V, Giordani, MT, Giostra, E, Sonzogni, A, Ruggiero, G, Marcellin, P, Powell, EE, George, J and Negro, F (2006). Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: A meta-analysis of individual patient data. Gastroenterology, 130 (6), 1636-1642. doi: 10.1053/j.gastro.2006.03.014 |
|
2005 Journal Article Steatosis is a cofactor in liver injury in hemochromatosisPowell, Elizabeth E., Ali, Azmat, Clouston, Andrew D., Dixon, Jeannette L., Lincoln, Douglas J., Purdie, David M., Fletcher, Linda M., Powell, Lawrie W. and Jonsson, Julie R. (2005). Steatosis is a cofactor in liver injury in hemochromatosis. Gastroenterology, 129 (6), 1937-1943. doi: 10.1053/j.gastro.2005.09.015 |
|
2005 Journal Article Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosisClouston, Andrew D., Powell, Elizabeth E., Walsh, Meagan J., Richardson, Michelle M., Demetris, A. Jake and Jonsson, Julie R. (2005). Fibrosis correlates with a ductular reaction in hepatitis C: Roles of impaired replication, progenitor cells and steatosis. Hepatology, 41 (4), 809-818. doi: 10.1002/hep.20650 |
|
2005 Journal Article Steatosis: Co-factor in other liver diseasesPowell, EE, Jonsson, JR and Clouston, AD (2005). Steatosis: Co-factor in other liver diseases. Hepatology, 42 (1), 5-13. doi: 10.1002/hep.20750 |
|
2005 Journal Article Dangerous liaisons: The metabolic syndrome and nonalcoholic fatty liver diseasePowell, EE, Jonsson, JR and Clouston, AD (2005). Dangerous liaisons: The metabolic syndrome and nonalcoholic fatty liver disease. Annals of Internal Medicine, 143 (10), 753-754. doi: 10.7326/0003-4819-143-10-200511150-00015 |
|
2005 Journal Article Adiponectin and its receptors in patients with chronic hepatitis CJonsson, JR, Moschen, AR, Hickman, IJ, Richardson, MM, Kaser, S, Clouston, AD, Powell, EE and Tilg, H (2005). Adiponectin and its receptors in patients with chronic hepatitis C. Journal of Hepatology, 43 (6), 929-936. doi: 10.1016/j.jhep.2005.05.030 |
|
2005 Conference Publication Hepatic progenitor cell expansion and a periportal ductular reaction in NAFLD - Relationship with impaired hepatocyte proliferation and fibrosis, and reversal with treatmentRichardson, M., Jonsson, J., Powell, E., Brunt, E. M., Bhathal, P., Dixon, J. and Clouston, A. (2005). Hepatic progenitor cell expansion and a periportal ductular reaction in NAFLD - Relationship with impaired hepatocyte proliferation and fibrosis, and reversal with treatment. 56th Annual Meeting of the American Association for the Study of Liver Diseases, San Francisco, CA, United States, 11-15 November 2005. HOBOKEN: JOHN WILEY & SONS INC. |
|
2005 Book Chapter Does NASH or NAFLD contribute to comorbidity of other liver diseases?Powell, Elizabeth E. (2005). Does NASH or NAFLD contribute to comorbidity of other liver diseases?. Fatty liver disease: NASH and related disorders. (pp. 276-288) edited by Geoffrey C. Farrell, Jacob George, Pauline de la M. Hall and Arthur J. McCullough. Oxford, United Kingdom: Blackwell. |
|
2005 Book Chapter Does NASH or NAFLD contribute to comorbidity of other liver diseases?Clouston, Andrew D. and Powell, Elizabeth E. (2005). Does NASH or NAFLD contribute to comorbidity of other liver diseases?. Fatty liver disease: NASH and related disorders. (pp. 276-288) edited by Geoffrey C. Farrell, Jacob George, Pauline de la M. Hall and Arthur J. McCullough. Malden, MA, United States: Blackwell Publishing. doi: 10.1002/9780470987438.ch23 |
|
2005 Conference Publication Obesity is associated with non-response to antiviral therapy and increased hepatic expression of SOCS-3 in chronic hepatitis CWalsh, M.J., Jonsson, J.R., Richardson, M.M., Lipka, G.M., Purdie, D.M., Clouston, A.D. and Powell, E.E. (2005). Obesity is associated with non-response to antiviral therapy and increased hepatic expression of SOCS-3 in chronic hepatitis C. 40th Annual Meeting of the European Association for the Study of the Liver, Paris, France, 13-17 April 2005. Amsterdam , Netherlands: Elsevier. |
|
2005 Journal Article A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis CRichardson, M. M., Powell, E. E., Barrie, H. D., Clouston, A. D., Purdie, D. M. and Jonsson, J. R. (2005). A combination of genetic polymorphisms increases the risk of progressive disease in chronic hepatitis C. Journal of Medical Genetics, 42 (7), 1-6. doi: 10.1136/jmg.2005.032557 |
|
2004 Journal Article Nonalcoholic fatty liver disease: is all the fat bad?Clouston, A. D. and Powell, E. E. (2004). Nonalcoholic fatty liver disease: is all the fat bad?. Internal Medicine Journal, 34 (4), 187-191. doi: 10.1111/j.1444-0903.2004.00574.x |
|
2004 Journal Article Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejectionJonsson, Julie R., Gu, Wenyi, Vanags, Daina M., Bishop, G. Alex, McCaughan, Geoffrey W., Fawcett, Jonathon, Lynch, Stephen V., Balderson, Glenda A., Powell, Elizabeth E. and Clouston, Andrew D. (2004). Increased mononuclear cell activation and apoptosis early after human liver transplantation is associated with a reduced frequency of acute rejection. Liver Transplantation, 10 (3), 397-403. doi: 10.1002/lt.20084 |
|
2004 Journal Article Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional studyBuntain, HM, Greer, RM, Schluter, PJ, Wong, JCH, Batch, JA, Potter, JM, Lewindon, PJ, Powell, E, Wainwright, CE and Bell, SC (2004). Bone mineral density in Australian children, adolescents and adults with cystic fibrosis: a controlled cross sectional study. Thorax, 59 (2), 149-155. doi: 10.1136/thorax.2003.006726 |
|
2004 Journal Article CCR5-Delta 32 mutation is strongly associated with primary sclerosing cholangitisEri, R, Jonsson, JR, Pandeya, N, Purdie, DM, Clouston, AD, Martin, N, Duffy, D, Powell, EE, Fawcett, J, Florin, THJ and Radford-Smith, GL (2004). CCR5-Delta 32 mutation is strongly associated with primary sclerosing cholangitis. Genes And Immunity, 5 (6), 444-450. doi: 10.1038/sj.gene.6364113 |
